MEHMET FATİH ERBAY, Tamer BAYSAL, Zeynep Ayfer AYTEMUR

The Role of First-Pass Perfusion Computed Tomography in the Differentiation of Centrally Located Lung Cancer and Distal Atelectasis

Our aim in this study was to differentiate postobstructive consolidation from lung cancer by means of first-pass perfusion CT in centrally located malignancies. We studied 20 patients (18 males and 2 females) diagnosed as lung cancer with untreated central masses and distal postobstructive atelectasis. In order to localize the slice position showing the appropriate mass-consolidation area to be included in contrast-enhanced dynamic imaging, we first performed scout and baseline acquisition without contrast media, followed by dynamic acquisition after intravenous contrast media injection. Three different ROIs were placed on the central mass while avoiding the peripheral regions as much as possible and on the peripheral locations of distal consolidation using dynamic contrast-enhanced images. The BV, BF, TTP and MTT perfusion parameters were automatically calculated in the ROI locations. We were able to differentiate the central masses from distal consolidations by means of statistical differences in the first-pass BV and BF parameters between the mass and distal consolidation areas. The mean values of parameters that were calculated in the mass and consolidation areas were BV:7.69±4.28 ml/100g, BF:48.87±25.54 ml/100g/min, TTP:27.94±7.32 sec., MTT:9.56±3.47 sec. and BV:11.83±5.34 ml/100g, BF:78.75±39.41 ml/100g/min, TTP:29.72±6.05 sec., MTT:11.44±4.93 sec., respectively. We concluded that first-pass perfusion CT may be used as a functional imaging method to differentiate central lung cancer from distal consolidation and could be useful in reducing the target cancer volume in patients who are candidates for radiation therapy.

PDF

___

1. Kiessling F, Boese J, Corvinus C, Ederle JR, Zuna I, Schoenberg SO, Brix G, Schmähl A, Tuengerthal S, Herth F, Kauczor HU, Essıg M. Perfusion CT in patients with advanced bronchial carcinomas: a novel chance for characterization and treatment monitoring? Eur Radiol. 2004;14(7):1226-33.

2. Kambadakone AR, Sahani DV. Body perfusion CT: technique, clinical applications, and advances. Radiol Clin North Am. 2009;47(1):161-78.

3. Miles KA, Charnsangavej C, Lee FT, Fishman EK, Horton K, Lee TY. Application of CT in the investigation of angiogenesis in oncology. Acad Radiol. 2000;7(10):840-50.

4. Miles KA. Perfusion imaging with computed tomography: brain and beyond. Eur Radiol. 2006;16 Suppl 7:M37-43.

5. Schaefer-Prokop C, Prokop M. New imaging techniques in the treatment guidelines for lung cancer. Eur Respir J Suppl. 2002;35:71s-83s.

6. Tyczynski JE, Parkin DM. Global epidemiology of lung cancer. In: Hirsch FR, Bunn PA, Kato H, MulshineJL, eds, IASLC Textbook of Prevention and Detection of Early Lung Cancer. 1 edition. London: Taylor&Francis. 2006;1-11.

7. Baysal T, Mutlu DY, Yologlu S. Diffusion-weighted magnetic resonance imaging in differentiation of postobstructive consolidation from central lung carcinoma. Magn Reson Imaging. 2009;27(10):1447-54.

8. Hyer J, Silvestri G. Diagnosis and Staging of Lung Cancer. Clin Chest Med. 2000;21(1):95-106.

9. Naidich DP, Webb WR, Muller NL. Lobar atelectasis. In: Naidich DP, Webb WR, Muller NL, Krinsky GA, ZerhouniEA, Siegelman SS, eds, Computed tomography and magnetic resonance imaging of the thorax. 3 edition. Philadelphia: Lippincott. 1999;228-41.

10. Woodring JH. Determining the cause of pulmonary atelectasis: a comparison of plain radiography and CT. AJR Am J Roentgenol. 1988;150(4):757-63.

11. Erasmus JJ, Sabloff BS. CT, positron emission tomography, and MRI in staging lung cancer. Clin Chest Med. 2008;29(1):39-57.

12. Tobler J, Levitt RG, Glazer HS, Moran J, Crouch E, Evens RG. Differentiation of proximal bronchogenic carcinoma from postobstructive lobar collapse by magnetic resonance imaging. Comparison with computed tomography. Invest Radiol. 1987;22(7):538-43.

13. Onitsuka H, Tsukuda M, Araki A, Murakami J, Torii Y, Masuda K. Differentiation of central lung tumor from postobstructive lobar collapse by rapid sequence computed tomography. J Thorac Imaging. 1991;6(2):28-31.

14. Ross JS, O'donovan PB, Novoa R, Mehta A, Buonocore E, Macıntyre WJ, Golish JA, Ahmad M. Magnetic resonance of the chest: initial experience with imaging and in vivo T1 and T2 calculations. Radiology. 1984;152(1):95-101.

15. Shioya S, Haida M, Ono Y, Fukuzaki M, Yamabayashi H. Lung cancer: differentiation of tumor, necrosis, and atelectasis by means of T1 and T2 values measured in vitro. Radiology. 1988;167(1):105-9.

16. Qi LP, Zhang XP, Tang L, Li J, Sun YS, Zhu GY. Using diffusion-weighted MR imaging for tumor detection in the collapsed lung: a preliminary study. Eur Radiol. 2009;19(2):333-41.

17. Vansteenkiste JF. Imaging in lung cancer: positron emission tomography scan. Eur Respir J Suppl. 2002;35:49s-60s.

18. Lee TY, Purdie TG, Stewart E. CT imaging of angiogenesis. Q J Nucl Med. 2003;47(3):171-87.

19. Miles KA. Functional computed tomography in oncology. Eur J Cancer. 2002;38(16):2079-84.

20. Cuenod CA, Fournier L, Balvay D, Guinebretière JM. Tumor angiogenesis: Pathophysiology and implications for contrast-enhanced MRI and CT assessment. Abdom Imaging. 2006;31(2):188-93.

21. Li WW. Tumor angiogenesis: molecular pathology, therapeutic targeting and imaging. Acad Radiol. 2000;7(10):800-11.

22. Li Y, Yang ZG, Chen TW, Deng YP, Yu JQ, Li ZL. Whole tumour perfusion of peripheral lung carcinoma: evaluation with first-pass CT perfusion imaging at 64- detector row CT. Clin Radiol. 2008;63(6):629-35.

23. Ma SH, Xu K, Xiao ZW, Wu M, Sun ZY, Wang ZX, Hu ZG, Dai X, Han MJ, Li YG. Peripheral lung cancer: relationship between multi-slice spiral CT perfusion imaging and tumor angiogenesis and cyclinD1 expression. Clin Imaging. 2007;31(3):165-77.

24. Ovali GY, Sakar A, Goktan C, Celik P, Yorgancioğlu A, Nese N, Pabuscu Y. Thorax perfusion CT in non-small cell lung cancer. Comput Med Imaging Graph. 2007;31(8):686-91.